Parvovirus B19: Twenty-five years in perspective

Pediatric and Developmental Pathology

Volumn 2, Issue 4, 1999, Pages 296-315

  Rogers, Beverly Barton ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Anemia; Diagnosis; Immunodeficiency; Parvovirus B19; Pregnancy

Indexed keywords

CHILDHOOD CANCER; CLINICAL FEATURE; COMORBIDITY; CYTOPATHOLOGY; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; FETUS OUTCOME; HEMATOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INTRAUTERINE INFECTION; NONHUMAN; ORGAN TRANSPLANTATION; PARVOVIRUS; PREGNANCY; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; VIRUS INFECTION; VIRUS ISOLATION; VIRUS PATHOGENESIS;

ADULT; CHILD; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; INFANT; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0033032606     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100249900128     Document Type: Review

References (156)

1. Cossart YE, Cant B, Field AM, Widdows D. Parvovirus-like particles in human sera. Lancet 1975;1:72-73.
2. Anderson MJ, Jones SE, Fisher-Hoch SP, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983;1:1378.
3. Pattison JR, Jones SE, Hodgson J, et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981;1:664-665.
4. Young NS, Mortimer PP, Moore JG, Humphries RK. Characterization of a virus that causes transient aplastic crisis. J Clin Invest 1984;73:224-230.
5. Cotmore SF, Tattersall P. Characterization and molecular cloning of a human parvovirus genome. Science 1984;226: 1161-1165.
6. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus 19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58:921-936.
7. Mori J, Beattie P, Melton DW, Cohen BJ, Clewley JP. Structure and mapping of the DNA of human parvovirus B19. J Gen Virol 1987;68:2797-2806.
8. von dem Borne AEGK, Bos MJE, Joustra-Maas N, Tromp JF, van Wijngaarden-du Bois R, Tetteroo PAT. A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br J Haematol 1986;63:35-46.
9. Brown KE, Hibbs JR, Gallinella G, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994;330:1192-1196.
10. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262:114-117.
11. Kerr JR, McQuaid S, Coyle PV. Expression of P antigen in parvovirus B19-infected bone marrow. N Engl J Med 1995;332:128.
12. Ozawa K, Kurtzman G, Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 1986;233:883-886.
13. Pallier C, Greco A, le Junter J, Saib A, Vassius I, Morinet F. The 3′ untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells. J Virol 1997;71:9482-9489.
14. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvoviral infection in humans. J Infect Dis 1985;152:257-265.
15. Morey AL, Ferguson DJP, Leslie KO, Taatjes DJ, Fleming KA. Intracellular localization of parvovirus B19 nucleic acid at the ultrastructural level by in situ hybridization with digoxigenin-labelled probes. Histochem J 1993;25: 421-429.
16. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K. Human parvovirus B19 nonstructural (NSI) protein induces apoptosis in erythroid lineage cells. J Virol 1998;72: 3018-3028.
17. Török TJ. Human parvovirus B19. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant, 4th ed. Philadelphia: W.B. Saunders, 1995;668-702.
18. Lunardi C, Tiso A, Borgato L, et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol 1998;28:936-948.
19. Takahashi M, Ito M, Sakamoto F, et al. Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions. J Cutan Pathol 1995;22:168-172.
20. Cooper CL, Choudhri SH. Answer to photo quiz II. Clin Infect Dis 1998;26:989.
21. Corman LC, Dolson DJ. Polyarteritis nodosa and parvovirus B19 infection. Lancet 1992;339:491.
22. Ager EA, Chin TDY, Poland JD. Epidemic erythema infectiosum. N Engl J Med 1966;275:1326-1331.
23. Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995;172:1360-1363.
24. Murray JC, Gresik MV, Leger F, McClain KL. B19 parvovirus-induced anemia in a normal child. Am J Pediatr Hematol Oncol 1993;15:420-423.
25. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989;321:519-523.
26. Faden H, Gary GW, Anderson LJ. Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Infect Dis 1992;15:595-597.
27. Sasaki T, Murai C, Muryoi T, et al. Persistent infection of human parvovirus B19 in a normal subject. Lancet 1995; 346:851.
28. Chambers LA, Rauck AM. Acute transient hemolytic anemia with a positive Donath-Landsteiner test following parvovirus B19 infection. J Pediatr Hematol Oncol 1996; 18:178-181.
29. Bertrand Y, Lefrere JJ, Leverger G, et al. Autoimmune haemolytic anaemia revealed by human parvovirus linked erythroblastopenia. Lancet 1985;2:382-383.
30. Smith MA, Shah NS, Lobel JS. Parvovirus B19 infection associated with reticulocytopenia and chronic autoimmune hemolytic anemia. Am J Pediatr Hematol Oncol 1989;11:167-169.
31. Nelson J, McCracken G. Recurrent fifth disease. Pediatr Infect Dis J 1997 (May);16:(Newsletter).
32. Nelson J, McCracken G. Recurrent fifth disease. Pediatr Infect Dis J 1997 (September);16:(Newsletter).
33. Andersen LJ, Tsou C, Parker RA, et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 1986;24:522-526.
34. Erdman DD, Usher MJ, Tsou C, et al. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol 1991;35:110-115.
35. Sloots T, Devine PL. Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19. Eur J Clin Microbiol Infect Dis 1996;15:758-761.
36. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989;84:1114-1123.
37. Young N, Mortimer P. Viruses and bone marrow failure. Blood 1984;63:729-737.
38. Rao SP, Miller ST, Cohen BJ. Transient aplastic crisis in patients with sickle cell disease: B19 parvovirus studies during a 7-year period. Am J Dis Childhood 1992;146: 1328-1330.
39. Saarinen UM, Chorba TL, Tattersall P, et al. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood 1986;67:1411-1417.
40. Serjeant GR, Serjeant BE, Thomas PW, Anderson MJ, Patou G, Pattison JR. Human parvovirus infection in homozygous sickle cell disease. Lancet 1993;341:1237-1240.
41. Goss GA, Szer J. Pancytopenia following infection with human parvovirus B19 as a presenting feature of hereditary spherocytosis in two siblings. Aust NZ J Med 1997;27: 86-87.
42. Ludmerer KM, Kissane JM, eds. Clinicopathologic Conference. Am J Med 1998;104:200-209.
43. Lowenthal EA, Prchal JT. Parvovirus B19 induced red blood cell aplasia in a patient with hereditary pyropoikilocytosis. Blood 1995;86:411-412.
44. Mallouh AA, Qudah A. Acute splenic sequestration together with aplastic crisis caused by human parvovirus B19 in patients with sickle cell disease. J Pediatr 1993;122: 593-595.
45. Lowenthal EA, Wells A, Emanuel PD, Player R, Prchal JT. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review. Am J Hematol 1996;51:207-213.
46. Goldstein LJ, Strenger R, King TC, Le SC, Rogers BB. Retrospective diagnosis of sickle cell-hemoglobin C disease and parvovirus infection by molecular DNA analysis of postmortem tissue. Hum Pathol 1995;26:1375-1378.
47. + thalassemia: a complication of acute parvovirus B19 infection. Pediatr Pathol Lab Med 1996;16:71-82.
48. Van Horn DK, Mortimer PP, Young N, Hanson GR. Human parvovirus-associated red cell aplasia in the absence of underlying hemolytic anemia. Am J Pediatr Hematol Oncol 1986;8:235-239.
49. Yoto Y, Kudoh T, Suzuki N, Matsunaga Y, Chiba S. Retrospective study on the influence of human parvovirus B19 infection among children with malignant diseases. Acta Haematol 1993;90:8-12.
50. Rao SP, Miller ST, Cohen BJ. Severe anemia due to B19 parvovirus infection in children with acute leukemia in remission. Am J Pediatr Hematol Oncol 1990;12:194-197.
51. Carstensen H, Ømvold K, Cohen BJ. Human parvovirus B19 infection associated with prolonged erythroblastopenia in a leukemic child. Pediatr Infect Dis J 1989;8:56.
52. Fisher D, Spencer D, Iland H, Brammah S, Cossart Y. Red cell aplasia caused by human parvovirus B19 in acute leukaemia. Aust NZ J Med 1992;22:303-304.
53. Smith MA, Shah NR, Lobel JS, Cera PJ, Gary GW, Anderson LJ. Severe anemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy. Clin Pediatr 1988;27:383-386.
54. Coulombel L, Morinet F, Mielot F, Tchernia G. Parvovirus infection, leukaemia, and immunodeficiency. Lancet 1989; 1:101-102.
55. Kurtzman GJ, Cohen B, Meyers P, Aminullah A, Young NS. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet 1988;2:1159-1162.
56. Weiland HT, Salimans MMM, Fibbe WE, Kluin PM, Cohen BJ. Prolonged parvovirus B19 infection with severe anemia in a bone marrow transplant recipient. Br J Haematol 1989;71:300.
57. Nour B, Green M, Michaels M, et al. Parvovirus B19 infection in pediatric transplant patients. Transplantation 1993;56:835-838.
58. Bertoni E, Rosati A, Zanazzi M, et al. Severe aplastic anaemia due to B19 parvovirus infection in renal transplant recipient. Nephrol Dial Transplant 1995;10:1462-1463.
59. Chang FY, Singh N, Gayowski T, Marino IR. Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients. Clin Transplant 1996;10:243-247.
60. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type I (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990;113:926-933.
61. Griffin TC, Squires JE, Timmons CF, Buchanan GR. Chronic human parvovirus B19-induced erythroid hypoplasia as the initial manifestation of human immunodeficiency virus infection. J Pediatr 1991;118:899-901.
62. Chernak E, Dubin G, Henry D, et al. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 1995;20:170-173.
63. van Elsacker-Niele AMW, Kroon FP, van der Ende ME, Salimans MMM, Spaan WJM, Kroes ACM. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1996;23:1255-1260.
64. Nelson AM, Abbondanzo SL, Fortunato RA, Sun YC, Shieh W-J, Zaki SR. Parvovirus B19 as a cause of anemia in human immunodeficiency virus (HIV) infected patients. Mod Pathol 1996;9:131A.
65. Zakrzewska K, Azzi A, Patou G, Morfini M, Rafanelli D, Pattison JR. Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction. Br J Haematol 1992;81:407-412.
66. Santagostino E, Mannucci PM, Gringeri A, et al. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100°C heat after lyophilization. Transfusion 1997;37:517-522.
67. Lyon DJ, Chapman CS, Martin C, et al. Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet 1989;1:1085.
68. Morfini M, Longo G, Rossi Ferrini P, et al. Letter to the Editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B19 parvovirus. Am J Hematol 1992;39: 149-150.
69. Nagai K, Morohoshi T, Kudoh T, Yoto Y, Suzuki N, Matsunaga Y. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection. Br J Haematol 1992;80:131-132.
70. Hanada T, Koike K, Hirano C, et al. Childhood transient erythroblastopenia complicated by thrombocytopenia and neutropenia. Eur J Haematol 1989;42:77-80.
71. Wodzinski MA, Lilleyman JS. Transient erythroblastopenia of childhood due to human parvovirus B19 infection. Br J Haematol 1989;73:127-131.
72. Bhambhani K, Inoue S, Sarnaik SA, Merline J. Transient erythroblastopenia of childhood not associated with human parvovirus infection. Lancet 1986;1:509.
73. Rogers BB, Rogers ZR, Timmons CF. Polymerase chain reaction amplification of archival material for parvovirus B19 in children with transient erythroblastopenia of childhood. Pediatr Pathol Lab Med 1996;16:471-478.
74. Yoto Y, Kudoh T, Suzuki N, Katoh S, Matsunaga Y, Chiba S. Thrombocytopenia induced by human parvovirus B19 infections. Eur J Haematol 1993;50:255-257.
75. Oeda E, Shinohara K, Inoue H, Nomiyama J. Parovovirus B19 infection causing severe peripheral blood thrombocytopenia and persistent viremia. Am J Hematol 1994;45: 274-275.
76. Assy N, Rosenthal E, Hazani A, Etzioni A, Baruch Y. Human parvovirus B19 infection associated with idiopathic thrombocytopenia purpura in a child following liver transplantation. J Hepatol 1997;27:934-936.
77. Murray JC, Kelley PK, Hogrefe WR, McClain KL. Childhood idiopathic thrombocytopenic purpura: association with human parvovirus B19 infection. Am J Pediatr Hematol Oncol 1994;16:314-319.
78. van Elsacker-Niele A-MW, Weiland HT, Kroes ACM, Kappers-Klunne MC. Parvovirus B19 infection and idiopathic thrombocytopenia purpura. Ann Hematol 1996;72:141-144.
79. Boruchoff SE, Woda BA, Pihan GA, Durbin WA, Burstein D, Blacklow NR. Parvovirus B19-associated hemophagocytic syndrome. Arch Intern Med 1990;150:897-899.
80. Muir K, Todd WTA, Watson WH, Fitzsimons E. Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia. Lancet 1992;339:1139-1140.
81. Tsuda H, Maeda Y, Nakagawa K, et al. Parvovirus B19-associated haemophagocytic syndrome with prominent neutrophilia. Br J Haematol 1994;86:413-414.
82. Shirono K, Tsuda H. Parvovirus B19-associated haemophagocytic syndrome in healthy adults. Br J Haematol 1995;89:923-926.
83. Hoang MP, Dawson DB, Rogers ZR, Scheuermann RH, Rogers BB. Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis. Hum Pathol 1998; 29:1074-1077.
84. Salimans MMM, Holsappel S, van de Rijke FM, Jiwa NM, Raap AK, Weiland HT. Rapid detection of human parvovirus B19 DNA by dot-hybridization and the polymerase chain reaction. J Virol Methods 1989;23:19-28.
85. Burton PA. Intranuclear inclusions in marrow of hydropic fetus due to parvovirus infection. Lancet 1986;2: 1155.
86. Krause JR, Penchansky L, Knisely AS. Morphological diagnosis of parvovirus B19 infection. Arch Pathol Lab Med 1992;116:178-180.
87. Taillan B, Heudier P, Ferrari E, Gamier G, Fuzibet J-G, Dujardin P. Pure red-cell aplasia due to parvovirus B19 infection in a patient with AIDS-related complex. Ann Med 1992;24:137.
88. Gahr M, Pekrun A, Eiffert H. Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia. Eur J Pediatr 1991;150:470-472.
89. Koduri PR. Novel cytomorphology of the giant pronormoblasts of parvovirus B19 infection. Am J Hematol 1998;58: 95-99.
90. Liu W, Ittmann M, Liu J, et al. Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using "in situ" hybridization and immunohistochemistry. Hum Pathol 1997;28:760-766.
91. Skjöldebrand-Sparre L, Fridell E, Nyman M, Wahren B. A prospective study of antibodies against parvovirus B19 in pregnancy. Acta Obstet Gynecol Scand 1996;75:336-339.
92. Guidozzi F, Ballot D, Rothberg AD. Human B19 parvovirus infection in an obstetric population. J Reprod Med 1994;39:36-38.
93. Gratacós E, Torres P-J, Vidal J, et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995;171:1360-1363.
94. Schwarz TF, Roggendorf M, Hottenträger B, et al. Human parvovirus B19 infection in pregnancy. Lancet 1988;2:566-567.
95. Harger JH, Adler SP, Koch WC, Harger GF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 1998;91:413-420.
96. Schwarz TF, Nerlich A, Hottenträger B, et al. Parvovirus B19 infection of the fetus. Am J Clin Pathol 1991;96:121-126.
97. Saller DN, Rogers BB, Canick JA. Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection. Prenat Diag 1993;13:467-471.
98. Petrikovsky BM, Baker D, Schneider E. Fetal hydrops secondary to human parvovirus infection in early pregnancy. Prenat Diagn 1996;16:342-344.
99. Chorba T, Coccia P, Holman RC, et al. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 1986;154:383-393.
100. Ray SM, Erdman DD, Berschling JD, Cooper JE, Török TJ, Blumberg HM. Nosocomial exposure to parvovirus B19: low risk of transmission to healthcare workers. Infect Control Hosp Epidemiol 1997;18:109-114.
101. Bell LM, Naides SJ, Stoffman P, Hodinka RL, Plotkin SA. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med 1989;321:485-491.
102. Carrington D, Gilmore DH, Whittle MJ, et al. Maternal serum alpha fetoprotein - a marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet 1987;1:433-435.
103. Bernstein IM, Capeless EL. Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B-19 infection. Obstet Gynecol 1989;74: 456-457.
104. Komischke K, Searle K, Enders G. Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without complications. Prenat Diagn 1997;17: 1039-1046.
105. Johnson DR, Fisher RA, Helwick JJ, Murray DL, Patterson MJ, Downes FP. Screening maternal serum alpha-fetoprotein levels and human parvovirus antibodies. Prenat Diagn 1994;14:455-458.
106. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990;300:1166-1170.
107. Rodis JF, Quinn DL, Gary GW, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 1990;163:1168-1171.
108. Rodis JF, Hovick TJ, Quinn DL, Rosengren SS, Tattersall P. Human parvovirus infection in pregnancy. Obstet Gynecol 1988;72:733-738.
109. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987;316:183-186.
110. Rogers BB, Mark Y, Oyer CE. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: I. Histology. Pediatr Pathol 1993;13:371-379.
111. Rodis JF, Rodner C, Hansen AA, Borgida AF, Deoliveira I, Rosengren SS. Long-term outcome of children following maternal human parvovirus B19 infection. Obstet Gynecol 1998;91:125-128.
112. Brown KE, Green SW, de Mayolo JA, et al. Congenital anemia after transplacental B19 parvovirus infection. Lancet 1994;343:895-896.
113. Donders GGG, van Lierde S, van Elsacker-Niele AMW, Moerman P, Goubau P, Vandenberghe K. Survival after intrauterine parvovirus B19 infection with persistence in early infancy: a two-year follow-up. Pediatr Infect Dis J 1994;13:234-236.
114. Heegaard ED, Hasle H, Clausen N, Hornsleth A, Kerndrup GB. Parvovirus B19 infection and Diamond-Black-fan anaemia. Acta Paediatr 1996;85:299-302.
115. Hartwig NG, Vermeij-Keers C, van Elsacker-Niele AMW, Fleuren GJ. Embryonic malformations in a case of intrauterine parvovirus B19 infection. Teratology 1989;39:295-302.
116. Tiessen RG, van Elsacker-Niele AMW, Vermeij-Keers C, Oepkes D, van Roosmalen J, Gorsira MCB. A fetus with a parvovirus B19 infection and congenital anomalies. Prenat Diagn 1994;14:173-176.
117. White FV, Jordan J, Dickman PS, Knisely AS. Fetal parvovirus B19 infection and liver disease of antenatal onset in an infant with Ebstein's anomaly. Pediatr Pathol Lab Med 1995;15:121-129.
118. Barton LL, Lax D, Shehab ZM, Keith JC. Congenital cardiomyopathy associated with human parvovirus B19 infection. Am Heart J 1997;133:131-133.
119. Mark Y, Rogers BB, Oyer CE. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: II. DNA amplification. Pediatr Pathol 1993;13:381-386.
120. Rogers BB. Case 5. Histopathologic variability of finding erythroid inclusions with intrauterine parvovirus B19 infection. Pediatr Pathol 1992;12:883-889.
121. Franciosi RA, Tattersall P. Fetal infection with human parvovirus B19. Hum Pathol 1988;19:489-491.
122. Field AM, Cohen BJ, Brown KE, et al. Detection of B19 parvovirus in human fetal tissues by electron microscopy. J Med Virol 1991;35:85-95.
123. Knisely AS, O'Shea PA, McMillan P, Singer DB, Magid MS. Electron microscopic identification of parvovirus virions in erythroid-line cells in fatal hydrops fetalis. Pediatr Pathol 1988;8:163-170.
124. Caul EO, Usher MJ, Burton PA. Intrauterine infection with human parvovirus B19: a light and electron microscopy study. J Med Virol 1988;24:55-66.
125. Nascimento JP, Hallam NF, Mori J, et al. Detection of B19 parvovirus in human fetal tissues by in situ hybridisation. J Med Virol 1991;33:77-82.
126. Salimans MMM, van de Rijke FM, Raap AK, van Elsacker-Niele AMW. Detection of parvovirus B19 DNA in fetal tissues by in situ hybridisation and polymerase chain reaction. J Clin Pathol 1989;42:525-530.
127. Porter HJ, Heryet A, Quantrill AM, Fleming KA. Combined non-isotopic in situ hybridisation and immunohistochemistry on routine paraffin wax embedded tissue: identification of cell type infected by human parvovirus and demonstration of cytomegalovirus DNA and antigen in renal infection. J Clin Pathol 1990;43:129-132.
128. Pilavdzic D, Lines LD, Petric M, Silver MM. Immunoelectron microscopic identification of human parvovirus B19. Ultrastruct Pathol 1994;18:417-422.
129. van Elsacker-Niele AMW, Salimans MMM, Weiland HT, Vermey-Keers C, Anderson MJ, Versteeg J. Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynaecol 1989;96:768-775.
130. Porter HJ, Quantrill AM, Fleming KA. B19 parvovirus infection of myocardial cells. Lancet 1988;2:535-536.
131. Wright C, Hinchliffe SA, Taylor C. Fetal pathology in intrauterine death due to parvovirus B19 infection. Br J Obstet Gynaecol 1996;103:133-136.
132. Vogel H, Komman M, Ledet SC, Rajagopalan L, Taber L, McClain K. Congenital parvovirus infection. Pediatr Pathol Lab Med 1997;17:903-912.
133. Rogers BB, Singer DB, Mak SK, Gary GW, Fikrig MK, McMillan PN. Detection of human parvovirus B19 in early spontaneous abortuses using serology, histology, electron microscopy, in situ hybridization, and the polymerase chain reaction. Obstet Gynecol 1993;81:402-408.
134. Sahakian V, Weiner CP, Naides SJ, Williamson RA, Scharosch LL. Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Am J Obstet Gynecol 1991;164:1090-1091.
135. Nikkari S, Ekblad U. A rapid and safe method to detect fetal parvovirus B19 infection in amniotic fluid by polymerase chain reaction: report of a case. Am J Perinatol 1995;12:447-449.
136. Peters MT, Nicolaides KH. Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol 1990;75:501-504.
137. Zerbini M, Musiani M, Gentilomi G, Venturoli S, Gallinella G, Morandi R. Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. J Clin Microbiol 1996;34: 603-608.
138. Török TJ, Wang Q-Y, Gary GW, Yang C-F, Finch TM, Anderson LJ. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. Clin Infect Dis 1992;14:149-155.
139. Gentilomi G, Zerbini M, Gallinella G, et al. B19 parvovirus induced fetal hydrops: rapid and simple diagnosis by detection of B19 antigens in amniotic fluids. Prenat Diagn 1998;18:363-368.
140. Woolf AD, Cohen BJ. Parvovirus B19 and chronic arthritis - causal or casual association? Am Rheum Dis 1995;54: 535-536.
141. Nocton JJ, Miller LC, Tucker LB, Schaller JG. Human parvovirus B19-associated arthritis in children. J Pediatr 1993;122:186-190.
142. Söderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997;349:1063-1065.
143. Kerr JR, Boyd N. Autoantibodies following parvovirus B19 infection. J Infect 1996;32:41-47.
144. Rogers BB. Nucleic acid amplification and infectious disease. Hum Pathol 1994;25:591-593.
145. Schowengerdt KO, Ni J, Denfield SW, et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection. Circulation 1997;96:3549-3554.
146. Okumura A, Ichikawa T. Aseptic meningitis caused by human parvovirus B19. Arch Dis Child 1993;68:784-785.
147. Koduri PR, Naides SJ. Aseptic meningitis caused by parvovirus B19. Clin Infect Dis 1995;21:1053.
148. Haseyama K, Kudoh T, Yoto Y, Suzuki N, Chiba S. Detection of human parvovirus B19 DNA in cerebrospinal fluid. Pediatr Infect Dis J 1997;16:324-326.
149. Cassinotti P, Schultze D, Schlageter P, Chevili S, Siegl G. Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 1993;12:701-704.
150. Heegaard ED, Peterslund NA, Hornsleth A. Parvovirus B19 infection associated with encephalitis in a patient suffering from malignant lymphoma. Scand J Infect Dis 1995;27:631-633.
151. Metzman R, Anand A, DeGiulio PA, Knisely AS. Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant. J Pediatr Gastroenterol Nutr 1989;9:112-114.
152. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet 1996;347:868-869.
153. Lewkonia RM, Home D, Dawood MR. Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis 1995;21:430-432.
154. Staud R, Corman LC. Association of parvovirus B19 infection with giant cell arteritis. Clin Infect Dis 1996;22: 1123.
155. Holm JM, Hansen LK, Oxhøj H. Kawasaki disease associated with parvovirus B19 infection. Eur J Pediatr 1995;134: 633-634.
156. Nigro G, Zerbini M, Krzysztofiak A, et al. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet 1994;343:1260-1261.